Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Statistics

Total Valuation

SGMT has a market cap or net worth of $159.37 million. The enterprise value is -$10.47 million.

Market Cap	159.37M
Enterprise Value	-10.47M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

SGMT has 32.20 million shares outstanding. The number of shares has increased by 527.36% in one year.

Current Share Class	30.67M
Shares Outstanding	32.20M
Shares Change (YoY)	+527.36%
Shares Change (QoQ)	+0.72%
Owned by Insiders (%)	10.00%
Owned by Institutions (%)	42.81%
Float	17.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.93
P/TBV Ratio	0.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.41, with a Debt / Equity ratio of 0.00.

Current Ratio	38.41
Quick Ratio	37.26
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.94% and return on invested capital (ROIC) is -21.27%.

Return on Equity (ROE)	-27.94%
Return on Assets (ROA)	-20.58%
Return on Capital (ROIC)	-21.27%
Revenue Per Employee	n/a
Profits Per Employee	-$3.75M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.36%
50-Day Moving Average	5.28
200-Day Moving Average	4.27
Relative Strength Index (RSI)	48.05
Average Volume (20 Days)	759,444

Short Selling Information

The latest short interest is 4.13 million, so 12.82% of the outstanding shares have been sold short.

Short Interest	4.13M
Short Previous Month	4.36M
Short % of Shares Out	12.82%
Short % of Float	23.14%
Short Ratio (days to cover)	1.37

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-45.73M
Pretax Income	-27.92M
Net Income	-37.52M
EBITDA	n/a
EBIT	-45.73M
Earnings Per Share (EPS)	-$1.29

Balance Sheet

The company has $152.49 million in cash and $116,000 in debt, giving a net cash position of $169.84 million or $5.28 per share.

Cash & Cash Equivalents	152.49M
Total Debt	116,000
Net Cash	169.84M
Net Cash Per Share	$5.28
Equity (Book Value)	170.68M
Book Value Per Share	5.30
Working Capital	153.10M

Cash Flow

Operating Cash Flow	-38.49M
Capital Expenditures	n/a
Free Cash Flow	-38.49M
FCF Per Share	-$1.20

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SGMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-527.36%
Shareholder Yield	-527.36%
Earnings Yield	-23.54%
FCF Yield	-24.15%

Analyst Forecast

The average price target for SGMT is $23.00, which is 364.65% higher than the current price. The consensus rating is "Buy".

Price Target	$23.00
Price Target Difference	364.65%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	111.65%
EPS Growth Forecast (5Y)	-3.01%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGMT has an Altman Z-Score of 18.28 and a Piotroski F-Score of 1.

Altman Z-Score	18.28
Piotroski F-Score	1